Distinct modulation of angiotensin II-induced early left ventricular hypertrophic gene programming by dietary fat type

Journal of Lipid Research

Volumn 47, Issue 6, 2006, Pages 1219-1226

  Földes, Gábor ^a   Vajda, Szilvia ^b   Lakó Futó, Zoltán ^a   Sármán, Balázs ^a   Skoumal, Réka ^a   Ilves, Mika ^c   DeChâtel, Rudolf ^a   Karádi, István ^a   Tóth, Miklós ^a   Ruskoaho, Heikki ^c   Leprán, István ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Cardiac hypertrophy; Fatty acids; Mitogen activated protein kinases; Signal transduction

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE SYNTHASE; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; FAT INTAKE; GENE EXPRESSION; GENETIC ASSOCIATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; LIPID BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DIETARY FATS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; HEART VENTRICLES; HYPERTROPHY, LEFT VENTRICULAR; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPIDS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER;

EID: 33744796528     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500550-JLR200     Document Type: Article

References (41)

1. Hu, F. B., J. E. Manson, and W. C. Willett. 2001. Types of dietary fat and risk of coronary heart disease: a critical review. J. Am. Coll. Nutr. 20: 5-19.
2. Simopoulos, A. P. 1999. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 70 (Suppl. 3): 560-569.
3. Taegtmeyer, H., and M. L. Overturf. 1988. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 11: 416-426.
4. Kagaya, Y., Y. Kanno, D. Takeyama, N. Ishide, Y. Maruyama, T. Takahashi, T. Ido, and T. Takishima. 1990. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study. Circulation. 81: 1353-1361.
5. Zahabi, A., and C. F. Deschepper. 2001. Long-chain fatty acids modify hypertrophic responses of cultured primary neonatal cardiomyocytes. J. Lipid Res. 42: 1325-1330.
6. Aguila, M. B., and C. A. Mandarim-de-Lacerda. 2001. Blood pressure, ventricular volume and number of cardiomyocyte nuclei in rats fed for 12 months on diets differing in fat composition. Mech. Ageing Dev. 122: 77-88.
7. Carroll, J. F., D. S. Braden, K. Cockrell, and H. L. Mizelle. 1997. Obese hypertensive rabbits develop concentric and eccentric hypertrophy and diastolic filling abnormalities. Am. J. Hypertens. 10: 230-233.
8. Chu, K. C., R. S. Sohal, S. C. Sun, G. E. Burch, and H. L. Colcolough. 1969. Lipid cardiomyopathy of the hypertrophied heart of goldthioglucose obese mice. J. Pathol. 97: 99-103.
9. Fitzgerald, S. M., J. R. Henegar, M. W. Brands, L. K. Henegar, and J. E. Hall. 2001. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R547-R552.
10. Sundstrom, J., L. Lind, B. Vessby, B. Andren, A. Aro, and H. Lithell. 2001. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation. 103: 836-841.
11. Rupp, H., V. Elimban, and N. S. Dhalla. 1992. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J. 6: 2349-2353.
12. Kelly, D. P., and A. W. Strauss. 1994. Inherited cardiomyopathies. N. Engl. J. Med. 330: 913-919.
13. Lepran, I., G. Nemecz, M. Koltai, and L. Szekeres. 1981. Effect of a linoleic acid-rich diet on the acute phase of coronary occlusion in conscious rats: influence of indomethacin and aspirin. J. Cardiovasc. Pharmacol. 3: 847-853.
14. Foldes, G., M. Suo, I. Szokodi, Z. Lako-Futo, R. deChatel, O. Vuolteenaho, P. Huttunen, H. Ruskoaho, and M. Toth. 2001. Factors derived from adrenals are required for activation of cardiac gene expression in angiotensin II-induced hypertension. Endocrinology. 142: 4256-4263.
15. Van der Vusse, G. J., T. H. Roemen, W. Flameng, and R. S. Reneman. 1983. Serum-myocardium gradients of non-esterified fatty acids in dog, rat and man. Biochim. Biophys. Acta. 752: 361-370.
16. Majalahti-Palviainen, T., M. Hirvinen, V. Tervonen, M. Ilves, H. Ruskoaho, and O. Vuolteenaho. 2000. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology. 141: 731-740.
17. Pikkarainen, S., H. Tokola, R. Kerkela, T. Majalahti-Palviainen, O. Vuolteenaho, and H. Ruskoaho. 2003. Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors. J. Biol. Chem. 278: 3969-3975.
18. Kerkela, R., S. Pikkarainen, T. Majalahti-Palviainen, H. Tokola, and H. Ruskoaho. 2002. Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene. J. Biol. Chem. 277: 13752-13760.
19. Yamamoto, K., Q. N. Dang, R. A. Kelly, and R. T. Lee. 1998. Mechanical strain suppresses inducible nitric-oxide synthase in cardiac myocytes. J. Biol. Chem. 273: 11862-11866.
20. Noronha, B. T., J. M. Li, S. B. Wheatcroft, A. M. Shah, and M. T. Kearney.2005. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes. 54: 1082-1089.
21. Grimsgaard, S., K. H. Bonaa, B. K. Jacobsen, and K. S. Bjerve. 1999. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension. 34: 478-483.
22. Tamaya-Mori, N., K. Uemura, and A. Iguchi. 2002. Gender differences in the dietary lard-induced increase in blood pressure in rats. Hypertension. 39: 1015-1020.
23. Hui, R., M. Robillard, J. H. Grose, M. Lebel, and P. Falardeau. 1991. Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the rat. Clin. Invest. Med. 14: 518-524.
24. Takemoto, M., K. Node, H. Nakagami, Y. Liao, M. Grimm, Y. Takemoto, M. Kitakaze, and J. K. Liao. 2001. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J. Clin. Invest. 108: 1429-1437.
25. Sellmayer, A., U. Danesch, and P. C. Weber. 1996. Effects of different polyunsaturated fatty acids on growth-related early gene expression and cell growth. Lipids. 31(Suppl): 37-40.
26. Zhou, Y. T., P. Grayburn, A. Karim, M. Shimabukuro, M. Higa, D. Baetens, L. Orci, and R. H. Unger. 2000. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. USA. 97: 1784-1789.
27. Diniz, Y. S., A. C. Cicogna, C. R. Padovani, L. S. Santana, L. A. Faine, and E. L. Novelli. 2004. Diets rich in saturated and polyunsaturated fatty acids: metabolic shifting and cardiac health. Nutrition. 20: 230-234.
28. Suo, M., J. Kalliovalkama, I. Porsti, P. Jolma, J. P. Tolvanen, O. Vuolteenaho, and H. Ruskoaho. 2002. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism. J. Cardiovasc. Pharmacol. 40: 478-486.
29. Yano, M., S. Kim, Y. Izumi, S. Yamanaka, and H. Iwao. 1998. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension. Circ. Res. 83: 752-760.
30. Purcell, N. H., G. Tang, C. Yu, F. Mercurio, J. A. DiDonato, and A. Lin. 2001. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc. Natl. Acad. Sci. USA. 98: 6668-6673.
31. Young, M. E., F. A. Laws, G. W. Goodwin, and H. Taegtmeyer. 2001. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J. Biol. Chem. 276: 44390-44395.
32. Sugden, P. H., and A. Clerk. 1998. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76: 725-746.
33. Jalili, T., J. Manning, and S. Kim. 2003. Increased translocation of cardiac protein kinase C beta2 accompanies mild cardiac hypertrophy in rats fed saturated fat. J. Nutr. 133: 358-361.
34. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298: 1911-1912.
35. Frey, N., and E. N. Olson. 2002. Modulating cardiac hypertrophy by manipulating myocardial lipid metabolism? Circulation. 105: 1152-1154.
36. Kacimi, R., and A. M. Gerdes. 2003. Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension. 41: 968-977.
37. Puigserver, P., J. Rhee, J. Lin, Z. Wu, J. C. Yoon, C. Y. Zhang, S. Krauss, V. K. Mootha, B. B. Lowell, and B. M. Spiegelman. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol. Cell. 8: 971-982.
38. Zhang, G. X., S. Kimura, A. Nishiyama, T. Shokoji, M. Rahman, and Y. Abe. 2004. ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction. Hypertension. 43: 117-124.
39. Wenzel, S., G. Taimor, H. M. Piper, and K. D. Schluter. 2001. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. FASEB J. 15: 2291-2293.
40. LaPointe, M. C., and E. Isenovic. 1999. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension. 33: 276-282.
41. Jiang, B., S. Xu, X. Hou, D. R. Pimentel, and R. A. Cohen. 2004. Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J. Biol. Chem. 279: 20363-20368.